Sugi Predict

Sugi Predict / Compounds / SCHEMBL609557

SCHEMBL609557

SCHEMBL609557

Cc1cc(C(F)(F)F)cc(O)n1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 P07900 1/20 0.39
▸ HSP90AB1 P08238 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.36
▸ SORT1 Q99523 1/20 0.36
▸ CES2 O00748 1/20 0.35
▸ GAA P10253 3/20 0.35
▸ S1PR1 P21453 1/20 0.34
▸ S1PR3 Q99500 1/20 0.34
▸ PSEN1 P49768 1/20 0.34
▸ PSEN2 P49810 1/20 0.34
▸ APH1B Q8WW43 1/20 0.34
▸ NCSTN Q92542 1/20 0.34
▸ APH1A Q96BI3 1/20 0.34
▸ PSENEN Q9NZ42 1/20 0.34
▸ PHGDH O43175 1/20 0.34
▸ POLQ O75417 1/20 0.34
▸ NR2E1 Q9Y466 1/20 0.33
▸ TACR1 P25103 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30744551 1.00 HSP90AA1 (0.39) HSP90AA1HSP90AB1KDM4ESORT1CES2
SCHEMBL8999929 0.84 CES2 (0.42) KDM4ECES2S1PR1S1PR3
SCHEMBL10025587 0.84 HSP90AA1 (0.46) HSP90AA1HSP90AB1SORT1CES2GAA
SCHEMBL31448288 0.77 HSP90AA1 (0.42) HSP90AA1HSP90AB1SORT1CES2GAA
SCHEMBL9013368 0.76 ADORA3 (0.47) HSP90AA1GAAS1PR1S1PR3
SCHEMBL24233010 0.76 CES2 (0.41) HSP90AA1HSP90AB1KDM4ECES2S1PR1
SCHEMBL10271822 0.76 HSP90AA1 (0.55) HSP90AA1HSP90AB1KDM4ECES2NR2E1
SCHEMBL9737789 0.76 HSP90AA1 (0.41) HSP90AA1HSP90AB1KDM4ESORT1GAA
SCHEMBL11109288 0.74 S1PR1 (0.36) KDM4ECES2S1PR1S1PR3
SCHEMBL11104202 0.74 S1PR1 (0.38) KDM4ECES2S1PR1S1PR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12384790-B2 Pteridinone compounds and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2025-08-12 — — US disclosed
CN-112218865-B Pteridinone compounds and uses thereof 沃泰克斯药物股份有限公司 2024-03-12 — — CN disclosed
EP-3356345-B1 HETEROARYL DERIVATIVES AS SEPIAPTERIN REDUCTASE INHIBITORS MAX PLANCK GESELLSCHAFT (DE) 2023-11-08 — — EP disclosed
EP-3784669-B1 PTERIDINONE COMPOUNDS AND USES THEREOF VERTEX PHARMA (US) 2023-10-25 — — EP disclosed
EP-3784669-B1 PTERIDINONE COMPOUNDS AND USES THEREOF VERTEX PHARMA (US) 2023-10-25 — — EP disclosed
US-20230312587-A1 PTERIDINONE COMPOUNDS AND USES THEREOF VERTEX PHARMACEUTICALS INCORPORATED 2023-10-05 — — US disclosed
US-20230312587-A1 PTERIDINONE COMPOUNDS AND USES THEREOF VERTEX PHARMACEUTICALS INCORPORATED 2023-10-05 — — US disclosed
US-20230312587-A1 PTERIDINONE COMPOUNDS AND USES THEREOF VERTEX PHARMACEUTICALS INCORPORATED 2023-10-05 — — US disclosed
US-11572364-B2 Pteridinone compounds and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-02-07 — — US disclosed
US-11572364-B2 Pteridinone compounds and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-02-07 — — US disclosed
CN-102970869-A Indoles GLAXOSMITHKLINE LLC 2013-03-13 — — CN disclosed
CN-102459229-A 3-azabicyclo [4.1.0] heptanes as orexin antagonists GLAXO GROUP LTD 2012-05-16 — — CN disclosed
EP-2421850-A1 3 -AZABICYCLO [4.1.0]HEPTANES USED AS OREXIN ANTAGONISTS Glaxo Group Limited (GB) 2012-02-29 — — EP disclosed
US-20120040991-A1 3-AZABICYCLO [4.1.0] HEPTANES USED AS OREXIN ANTAGONISTS GLAXO GROUP LIMITED (GB) 2012-02-16 — — US disclosed
US-20100331348-A1 TROPANE DERIVATIVES USEFUL AS PESTICIDES SYNGENTA CROP PROTECTION, INC. (US) 2010-12-30 — — US disclosed
WO-2010122151-A1 3 -AZABICYCLO [4.1.0] HEPTANES USED AS OREXIN ANTAGONISTS GLAXO GROUP LIMITED (GB) 2010-10-28 — — WO disclosed
WO-2009138758-A2 BIS-ARYL COMPOUNDS FOR USE AS MEDICAMENTS BIOLIPOX AB (SE) 2009-11-19 — — WO disclosed
CN-1189155-A Process for preparation of 2-(6-substituted pyrid-2-yloxymethyl) phenylacetate ZENECA LTD (GB) 1998-07-29 — — CN disclosed
EP-0840726-A1 PROCESS FOR THE PREPARATION OF 2-(6-SUBSTITUTED PYRID-2-YLOXYMETHYL)PHENYLACETATE ZENECA LIMITED (GB) 1998-05-13 — — EP disclosed
WO-1997001538-A1 PROCESS FOR THE PREPARATION OF 2-(6-SUBSTITUTED PYRID-2-YLOXYMETHYL)PHENYLACETATE ZENECA LIMITED (GB) 1997-01-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11572364-B2 Pteridinone compounds and uses thereof DPYD, PKD1, TYMP HSP90AA1 4648/4885HSP90AB1 4523/4885KDM4E 730/4885
US-20120040991-A1 3-AZABICYCLO [4.1.0] HEPTANES USED AS OREXIN ANTAGONISTS HCRTR2, HCRTR1, NPY2R HSP90AA1 2454/4885HSP90AB1 1993/4885KDM4E 1115/4885
US-20100331348-A1 TROPANE DERIVATIVES USEFUL AS PESTICIDES DDT, ACHE, TPM3 HSP90AA1 1447/4885HSP90AB1 1803/4885KDM4E 3763/4885
US-20230312587-A1 PTERIDINONE COMPOUNDS AND USES THEREOF DPYD, PKD1, TYMP HSP90AA1 4648/4885HSP90AB1 4523/4885KDM4E 730/4885
US-12384790-B2 Pteridinone compounds and uses thereof DPYD, PKD1, TYMP HSP90AA1 4648/4885HSP90AB1 4523/4885KDM4E 730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.